Comparison of Serum Free and Bioavailable 25-Hydroxyvitamin D Levels in Alzheimer's Disease and Healthy Control Patients

Ertilav E., BARCIN N. E., ÖZDEM S.

LABORATORY MEDICINE, cilt.52, sa.3, ss.219-225, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 52 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1093/labmed/lmaa066
  • Dergi Adı: LABORATORY MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.219-225
  • Anahtar Kelimeler: Alzheimer's disease, free 25-hydroxyvitamin D, bioavailable 25-hydroxyvitamin D, cognitive impairment, dementia, vitamin D binding protein, VITAMIN-D DEFICIENCY, D-BINDING PROTEIN, RISK, 1-ALPHA-HYDROXYLASE, DEMENTIA
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Objective: Many studies have investigated lower 25-hydroxyvitamin D (25[OH]D) levels in patients with Alzheimer's disease (AD) compared with those in control patients. In the present study, we aimed to evaluate serum free and bioavailable 25(OH)D levels in patients with AD and in healthy control patients.